(Q79931939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Steve Warrington

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kathy Baisley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kate Dunn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Anna Morocutti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

19 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

685-691

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16850327%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-006-0148-5

27 December 2019

exact match

0 references

cites work

Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects

1 reference

12 December 2020

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial

1 reference

12 December 2020

Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease

1 reference

12 December 2020

Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors

1 reference

12 December 2020

Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole

1 reference

12 December 2020

Once-Daily Bedtime Dose of Roxatidine and Ranitidine in Acute Duodenal Ulcer: A Combined Assessment of Acid Inhibitory Activity and Healing Rate

1 reference

12 December 2020

Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates

1 reference

12 December 2020

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

1 reference

12 December 2020

Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications

1 reference

12 December 2020

Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.

1 reference

12 December 2020

A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

1 reference

12 December 2020

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

12 December 2020

Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects

1 reference

12 December 2020

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

1 reference

12 December 2020

Integrated acidity and rabeprazole pharmacology

1 reference

12 December 2020

Comparative effectiveness of the antisecretory action of rabeprazole and esomeprazole in people with rapid metabolism of proton pump inhibitors

1 reference

12 December 2020

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms

1 reference

12 December 2020

The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease

1 reference

12 December 2020

The proton-pump inhibitors: similarities and differences

1 reference

12 December 2020

Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs

1 reference

12 December 2020

Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders

1 reference

12 December 2020